Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Long-term gene therapy in the CNS: Reversal of hypothalamic diabetes insipidus in the Brattleboro rat by using an adenovirus expressing arginine vasopressin

Nature Medicine volume 3, pages 1402–1404 (1997)Cite this article

Abstract

The ability of adenovirus (Ad) to transfect most cell types efficiently1–3 has already resulted in human gene therapy trials involving the systemic administration of adenoviral constructs4. However, because of the complexity of brain function and the difficulty in noninvasively monitoring alterations in neuronal gene expression, the potential of Ad gene therapy strategies for treating disorders of the CNS has been difficult to assess. In the present study, we have used an Ad encoding the arginine vasopressin cDNA (AdAVP)5 in an AVP-deficient animal model of diabetes insipidus (the Brattleboro rat6), which allowed us to monitor chronically the success of the gene therapy treatment by noninvasive assays. Injection of AdAVP into the supraoptic nuclei (SON) of the hypothalamus resulted in expression of AVP in magnocellular neurons. This was accompanied by reduced daily water intake and urine volume, as well as increased urine osmolality lasting 4 months. These data show that a single gene defect leading to a neurological disorder can be corrected with an adenovirus-based strategy. This study highlights the potential of using Ad gene therapy for the long-term treatment of disorders of the CNS.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Cheng, D.Y., Kolls, J.K., Lei, D.H. & Noel, R.A. In vivo and in vitro gene transfer and expression in rat intestinal epithelial cells by E1-deleted adenoviral vector. Hum. Gene Ther. 8, 755–764 (1997).

    Article  CAS  Google Scholar 

  2. Neve, R.L. Adenoviral vectors enter the brain. Trends Neurosci. 16, 251–253 (1993).

    Article  CAS  Google Scholar 

  3. Geddes, B.J. et al. Persistent transgene expression in the hypothatamus following stereotaxic delivery of a recombinant adenovirus- suppression of the immune response with cyclosporine. Endocrinology 137, 5166–5169 (1996).

    Article  CAS  Google Scholar 

  4. Wagner, J.A. & Gardner, P. Toward cystic fibrosis gene therapy. Anna. Rev. Med. 48, 203–216 (1997).

    Article  CAS  Google Scholar 

  5. Foo, N-C., Funkhouser, J.M., Carter, D.A. & Murphy, D. A testis-specific promoter in the rat vasopressin gene. J. Biol. Chem. 269, 659–667 (1994).

    CAS  PubMed  Google Scholar 

  6. Valtin, H. Hereditary diabetes insipidus in rats (Brattleboro strain). Am. J. Med. 42, 814–827 (1967).

    Article  CAS  Google Scholar 

  7. Gainer, H. & Wray, S. Cellular and molecular biology of oxytocin and vasopressin. in The Physiology of Reproduction, 2nd edn. (eds. E. Knobil & Neill) 4545–472 (Raven, New York, 1994).

    Google Scholar 

  8. Burbach, J.P.H. et al. Differential responses to osmotic stress of vasopressin mRNA in hypothalamic nuclei. Neuroendocrinology 39, 582–584 (1984).

    Article  CAS  Google Scholar 

  9. Sherman, T.G., Civelli, O., Douglas, J., Herbert, E. & Watson, S.J. Coordinate expression of hypothalamic pro-dynorphin and pro-vasopressin mRNAs with osmotic stimulation. Neuroendocrinology 44, 222–228 (1986).

    Article  CAS  Google Scholar 

  10. Schmale, H. & Richter, D. Single base deletion in the vasopressin gene is the cause of diabetes insipidus in Brattleboro rats. Nature 308, 705–709 (1984).

    Article  CAS  Google Scholar 

  11. Ivell, R., Burback, P.H. & Van Leeuwen, F.W. The molecular biology of the Brattleboro rat. Front. Neuroendocrinol. 4, 313–338 (1990).

    Google Scholar 

  12. Repaske, D.R. & Phillips, J.A. The molecular biology of human hereditary diabetes insipidus. Prog. Brain Res. 93, 295–308 (1992).

    Article  CAS  Google Scholar 

  13. Jirikowski, G.F., Sanna, P.P., Maciejewski-Lenoir, D. & Bloom, F.E. Reversal of diabetes insipidus in Brattleboro rats: Intrahypothalamic injection of vasopressin mRNA. Science 255, 996–998 (1992).

    Article  CAS  Google Scholar 

  14. Ben-Barak, Y., Russell, J.T., Whitnall, M.H., Ozato, K. & Gainer, H. Neurophysin in the hypothalamo-neurohypophysial system. I. Production and characterization of monoclonal antibodies. J. Neurosci. 5, 81–97 (1985).

    Article  CAS  Google Scholar 

  15. van Leeuwen, F.W., Evans, D.A.P., Meloen, R. & Sonnemans, M.A.F. Differential neurophysin immunoreactivities in solitary magnocellular neurons of the homozygous Brattleboro rat indicate an altered neurophysin moiety. Brain Res. 635, 328–330 (1994).

    Article  CAS  Google Scholar 

  16. Whitnall, M.H., Key, S., Ben-Barak, Y., Ozato, K. & Gainer, H. Neurophysin in the hypothalamo-neurohypophysial system. II. immunocytochemical studies of the ontogeny of oxytocinergic and vasopressinergic neurones. J. Neurosci. 5, 98–109 (1985).

    Article  CAS  Google Scholar 

  17. Pow, D.V., Morris, J.F. & Ward, A.R. Immuno-electron microscopic evidence for two different types of partial somatic repair of the mutant Brattleboro vasopressin gene. Neuroscience 50, 503–512 (1992).

    Article  CAS  Google Scholar 

  18. Graham, F.L. & Prevec, L. Methods for construction of adenovirus vectors. Mol. Biotech. 3, 207–220 (1995).

    Article  CAS  Google Scholar 

  19. Sofroniew, M.V. (1985) Vasopressin, oxytocin and their related neurophysins. in Handbook of Chemical Neuroanatomy. Vol. 4: GABA and neuropeptides in the CNS, Part 1 (eds. Bjorklund, A. & Hokfelt, T.) 35–44 (Elsevier, London, 1985).

    Google Scholar 

  20. Harbuz, M.S. & Lightman, S.L. Response of hypothalamic and pituitary mRNA to physical and psychological stress in the rat. J. Endo. (Lond.) 122, 705–711 (1989).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine Laboratories, University of Bristol, Marlborough Street, Bristol, UK, BS2 8HW

    Brad J. Geddes, Tom C. Harding, Stafford L. Lightman & James B. Uney

Authors
  1. Brad J. Geddes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tom C. Harding
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stafford L. Lightman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. James B. Uney
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Geddes, B., Harding, T., Lightman, S. et al. Long-term gene therapy in the CNS: Reversal of hypothalamic diabetes insipidus in the Brattleboro rat by using an adenovirus expressing arginine vasopressin. Nat Med 3, 1402–1404 (1997). https://doi.org/10.1038/nm1297-1402

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1297-1402

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing